KalVista Pharmaceuticals, Inc. (KALV) · INSIDERData sourcesSEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago
Public companyKalVista Pharmaceuticals, Inc.
KALVCIK 0001348911
Price$27.00
1 year+0.0%
Disclosed transactions58
Buys / sells0 / 9
Max Insider Score48
Connections with evidence7
KALV · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 40.0K sh | Jun 11, 2026 | Jun 11, 2026 |
| 9 | ABArif BilalChief Operations Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 40.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 9 | SBSensenig BethanyDirector | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 45.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 150.3K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 25.8K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 9 | TPTreanor PatrickDirector | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 10.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 9 | TPTreanor PatrickDirector | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 30.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 55.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 21.7K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 9 | TPTreanor PatrickDirector | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 10.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 68.8K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 59.3K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 9 | TPTreanor PatrickDirector | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 17.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 5 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 68.8K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 9 | ABArif BilalChief Operations Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 49.0K sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 11 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | May 22, 2026 | May 27, 2026 traded May 22, 2026 | +5d | SEC Form 4 | |
| 20 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $60K 2,239 sh | May 26, 2026 | May 27, 2026 traded May 26, 2026 | +1d | SEC Form 4 | |
| 15 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | May 22, 2026 | May 27, 2026 traded May 22, 2026 | +5d | SEC Form 4 | |
| 15 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | May 21, 2026 | May 26, 2026 traded May 21, 2026 | +5d | SEC Form 4 | |
| 20 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $72K 2,685 sh | May 22, 2026 | May 26, 2026 traded May 22, 2026 | +4d | SEC Form 4 | |
| 11 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | May 21, 2026 | May 26, 2026 traded May 21, 2026 | +5d | SEC Form 4 | |
| 9 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 16, 2026 | Apr 20, 2026 traded Apr 16, 2026 | +4d | SEC Form 4 | |
| 9 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 16, 2026 | Apr 20, 2026 traded Apr 16, 2026 | +4d | SEC Form 4 | |
| 27 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $38K 1,862 sh | Apr 17, 2026 | Apr 20, 2026 traded Apr 17, 2026 | +3d | SEC Form 4 | |
| 13 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 16, 2026 | Apr 20, 2026 traded Apr 16, 2026 | +4d | SEC Form 4 | |
| 9 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 16, 2026 | Apr 20, 2026 traded Apr 16, 2026 | +4d | SEC Form 4 | |
| 5 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 16, 2026 | Apr 20, 2026 traded Apr 16, 2026 | +4d | SEC Form 4 | |
| 30 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $54K 2,686 sh | Apr 17, 2026 | Apr 20, 2026 traded Apr 17, 2026 | +3d | SEC Form 4 | |
| 9 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 16, 2026 | Apr 20, 2026 traded Apr 16, 2026 | +4d | SEC Form 4 | |
| 31 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $38K 1,862 sh | Apr 17, 2026 | Apr 20, 2026 traded Apr 17, 2026 | +3d | SEC Form 4 | |
| 11 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Grant or award | A | — 100.0K sh | Jan 16, 2026 | Jan 21, 2026 traded Jan 16, 2026 | +5d | SEC Form 4 | |
| 11 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Grant or award | A | — 100.0K sh | Jan 16, 2026 | Jan 21, 2026 traded Jan 16, 2026 | +5d | SEC Form 4 | |
| 11 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Grant or award | A | — 100.0K sh | Jan 16, 2026 | Jan 21, 2026 traded Jan 16, 2026 | +5d | SEC Form 4 | |
| 15 | ABArif BilalChief Operations Officer | KALVKalVista Pharmaceuticals, Inc. Grant or award | A | — 49.0K sh | Jan 16, 2026 | Jan 21, 2026 traded Jan 16, 2026 | +5d | SEC Form 4 | |
| 23 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Nov 21, 2025 | Dec 4, 2025 traded Nov 21, 2025 | +13d | SEC Form 4 | |
| 23 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | Nov 22, 2025 | Dec 4, 2025 traded Nov 22, 2025 | +12d | SEC Form 4 | |
| 48 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $51K 3,813 sh | Nov 24, 2025 | Dec 4, 2025 traded Nov 24, 2025 | +10d | SEC Form 4 | |
| 23 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Nov 21, 2025 | Dec 4, 2025 traded Nov 21, 2025 | +13d | SEC Form 4 | |
| 23 | SNSweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | Nov 22, 2025 | Dec 4, 2025 traded Nov 22, 2025 | +12d | SEC Form 4 | |
| 15 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 15.0K sh | Nov 21, 2025 | Nov 26, 2025 traded Nov 21, 2025 | +5d | SEC Form 4 | |
| 11 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | Nov 22, 2025 | Nov 26, 2025 traded Nov 22, 2025 | +4d | SEC Form 4 | |
| 30 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $71K 5,296 sh | Nov 24, 2025 | Nov 26, 2025 traded Nov 24, 2025 | +2d | SEC Form 4 | |
| 15 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | Nov 22, 2025 | Nov 26, 2025 traded Nov 22, 2025 | +4d | SEC Form 4 | |
| 42 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $60K 4,471 sh | Nov 24, 2025 | Nov 26, 2025 traded Nov 24, 2025 | +2d | SEC Form 4 | |
| 15 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Nov 21, 2025 | Nov 26, 2025 traded Nov 21, 2025 | +5d | SEC Form 4 | |
| 11 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Nov 21, 2025 | Nov 26, 2025 traded Nov 21, 2025 | +5d | SEC Form 4 | |
| 23 | PBPiekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 15.0K sh | Nov 21, 2025 | Nov 26, 2025 traded Nov 21, 2025 | +5d | SEC Form 4 | |
| 21 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 2,419 sh | Nov 17, 2025 | Nov 19, 2025 traded Nov 17, 2025 | +2d | SEC Form 4 | |
| 31 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $45K 3,075 sh | Nov 18, 2025 | Nov 19, 2025 traded Nov 18, 2025 | +1d | SEC Form 4 | |
| 13 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,447 sh | Nov 17, 2025 | Nov 19, 2025 traded Nov 17, 2025 | +2d | SEC Form 4 | |
| 9 | AKAudhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 4,028 sh | Nov 17, 2025 | Nov 19, 2025 traded Nov 17, 2025 | +2d | SEC Form 4 | |
Chief Commercial Officer · Dec 4, 2025